Zylö Therapeutics
PrivateLast Round
Grant
May 31, 2023
Total Funding Raised
$13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Zylö Therapeutics is a biotechnology company developing a topical delivery system using engineered amorphous silica particles to encapsulate compounds for sustained release.
Sector
Healthcare & Life Sciences
Verticals
Advanced Materials, Biotechnology, Fashion & Beauty, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zylö Therapeutics Comparables
Compare Zylö Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermaliq Therapeutics, Inc. | 75% | |
| Incaptek | 72% | |
| Symbio | 65% |
Zylö Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 31, 2023 | ||||
| Grant | Aug 19, 2022 | ||||
| Series B | Jun 4, 2022 | ||||
| VC Round | Dec 7, 2021 | ||||
| Series A | Sep 21, 2019 |
Zylö Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| United States Department of Defense | Grant |
| Chemical Angel Network | Series A |
| Ariel Savannah Angel Partners | Series A |
| SC Launch | Series A, VC Round, Series B |
| Harvard Business School Alumni Angels of Greater New York | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 87% MoM.
- May 12, 2026
Monthly visitors increased 70% MoM.
Zylö Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zylö Therapeutics's valuation, stock price, and market status.
Is Zylö Therapeutics a public or private company?
Zylö Therapeutics is a private company.
What is the current stock price of Zylö Therapeutics?
Zylö Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Zylö Therapeutics worth (valuation)?
Valuation information for Zylö Therapeutics is not publicly available.
Can I buy Zylö Therapeutics stock?
Zylö Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zylö Therapeutics's last funding round?
Funding round information for Zylö Therapeutics is not publicly available.
Who are the main investors in Zylö Therapeutics?
Investor information for Zylö Therapeutics is not publicly disclosed.
Will Zylö Therapeutics IPO soon?
No public IPO plans have been announced for Zylö Therapeutics.
How can I track Zylö Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zylö Therapeutics's secondary market activity and sign up for updates.